Merck KGaA (MKKGY)
32.51
-0.32
(-0.97%)
USD |
OTCM |
Nov 19, 16:00
Merck Enterprise Value : 30.96B for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 30.96B |
| November 18, 2026 | 31.16B |
| November 17, 2026 | 31.32B |
| November 16, 2026 | 31.13B |
| November 13, 2026 | 31.32B |
| November 12, 2026 | 31.03B |
| November 11, 2026 | 31.82B |
| November 10, 2026 | 31.74B |
| November 09, 2026 | 31.78B |
| November 06, 2026 | 31.38B |
| November 05, 2026 | 31.52B |
| November 04, 2026 | 31.98B |
| November 03, 2026 | 31.41B |
| November 02, 2026 | 31.73B |
| October 30, 2026 | 31.71B |
| October 29, 2026 | 31.71B |
| October 28, 2026 | 31.02B |
| October 27, 2026 | 30.79B |
| October 26, 2026 | 30.68B |
| October 23, 2026 | 30.68B |
| October 22, 2026 | 31.21B |
| October 21, 2026 | 30.77B |
| October 20, 2026 | 31.33B |
| October 19, 2026 | 30.80B |
| October 16, 2026 | 30.80B |
| Date | Value |
|---|---|
| October 15, 2026 | 30.67B |
| October 14, 2026 | 30.38B |
| October 13, 2026 | 29.91B |
| October 12, 2026 | 29.97B |
| October 09, 2026 | 30.02B |
| October 08, 2026 | 29.84B |
| October 07, 2026 | 30.22B |
| October 06, 2026 | 30.14B |
| October 05, 2026 | 29.78B |
| October 02, 2026 | 29.90B |
| October 01, 2026 | 29.41B |
| September 30, 2026 | 30.05B |
| September 29, 2026 | 32.19B |
| September 28, 2026 | 32.42B |
| September 25, 2026 | 31.90B |
| September 24, 2026 | 31.76B |
| September 23, 2026 | 31.44B |
| September 22, 2026 | 31.64B |
| September 21, 2026 | 31.60B |
| September 18, 2026 | 31.19B |
| September 17, 2026 | 31.44B |
| September 16, 2026 | 31.43B |
| September 15, 2026 | 31.45B |
| September 14, 2026 | 31.40B |
| September 11, 2026 | 31.64B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| STRATEC SE | 1.900B |
| Sartorius AG | 16.99B |
| Petros Pharmaceuticals, Inc. | -3.388M |
| Agilent Technologies, Inc. | 51.63B |
| Bio-Rad Laboratories, Inc. | 9.580B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 517.73M |
| Revenue (Quarterly) | 6.474B |
| Total Expenses (Quarterly) | 5.956B |
| EPS Diluted (Quarterly) | 0.2382 |
| Gross Profit Margin (Quarterly) | 60.05% |
| Profit Margin (Quarterly) | 8.00% |
| Earnings Yield | 3.16% |
| Operating Earnings Yield | 6.85% |
| Normalized Earnings Yield | 3.799 |